Orgenesis Inc. has announced a regulatory issue concerning its listing status on the OTC Markets. On June 2, 2025, the OTC Markets Group informed the company that its common stock would be moved from the OTCQX tier to the Pink Limited tier, effective June 3, 2025. This decision follows Orgenesis Inc.'s failure to file its 10-K report for the period ending December 31, 2024, which is a requirement for continued qualification under the OTCQX Rules. The company did not address this deficiency within the 45-day cure period allowed.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orgenesis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-014075), on June 06, 2025, and is solely responsible for the information contained therein.
Comments